Facebook Linkedin Twitter
Inside Precision Medicine Alnylam’s Vutrisiran Gets Good Results for Cardiac Amyloidosis

RNA-based therapeutics

Image of a heart with a DNA double helix in front of it to indicate cardiovascular disease and the impact of transthyretin amyloid cardiomyopathy (ATTR-CM) which can be treated with vutrisiran.
News & Features

Alnylam’s Vutrisiran Gets Good Results for Cardiac Amyloidosis

Helen Albert -
0
ribonicleic acid chain from which can be used to make RNA silencing treatments for conditions such as congenital melanocytic nevus syndrome
News & Features

RNA Silencing Therapy Could Help Treat Rare Skin Condition

Helen Albert -
0
Injection in the arm
News & Features

RNA Direct Injection: A New Treatment for Cancer, Autoimmune Disease, and Gene Therapy

Kathy Vuksanaj -
0
Young woman lying on a bed undergoing kidney dialysis to treat diabetic kidney disease
News & Features

Quebec Project to Tackle Diabetic Kidney Disease

Helen Albert -
0
Image showing the translation of a protein with the help of tRNA and ribosomes
News & Features

hC Bioscience Will Target Hemophilia A with Modified tRNA Therapy

Helen Albert -
0
Molecule of mRNA, illustration
Informatics

Atomic AI’s Large Language Model Employs Chemical Mapping Data to Optimize RNA Therapies

Chris Anderson -
0
Pancreatic cancer, pancreas with PDAC, illustration
News & Features

A New Approach to Pancreatic Cancer Treatment Shows Potential for Increased Survival

Larissa Warneck -
0
Tech DNA
Molecular Dx

Nanopore and U of Queensland Partner on mRNA Vaccine and Drug Testing

Malorye Branca -
0
Micro RNA (miRNA)
News & Features

First-in-Class microRNA Cancer Therapy Shows Potential in Early Studies

Chris Anderson -
0
3D illustration of ribonucleic acid (RNA) strands
Molecular Dx

ADARx Nets $200M for Lead siRNA Drug Candidates

Malorye Branca -
0
123...6Page 1 of 6

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine